Pharma Focus Asia
KP - Choose our fully recyclable blister films

FDA Approves ImPact Biotech's Phase 1 Clinical Programme for Padeliporfin VTP in Lung Cancer

Saturday, August 05, 2023

ImPact Biotech has received clearance from the U.S. Food and Drug Administration for clinical investigation plan involving Padeliporfin Vascular Targeted Photodynamic (VTP) therapy. This therapy is intended for treating patients with Peripheral Lung Cancer.

The planned Phase 1/1b study is structured to evaluate the safety, feasibility, and optimal light dosage of Padeliporfin Vascular Targeted Photodynamic (VTP) therapy and to show that the Padeliporfin VTP provides a safe and effective treatment enabling patients and doctors to have an extra therapy option to directly target the disease.

This comprehensive study will be conducted across multiple centres and will follow an open-label approach. The methodology involves employing Robotic Assisted Bronchoscopy and cone beam CT guidance to facilitate precise lung tumour ablation in individuals diagnosed with Peripheral Lung Cancer.

Padeliporfin VTP is a minimally invasive oncology platform designed to treat solid tumours. This approach combines surgical efficacy with the preservation of healthy tissue and organs. The therapy involves intravenously delivering an inactive drug, Padeliporfin, which is then activated by light.

When activated, the drug causes the blood supply in the illuminated area to constrict, leading to targeted tumour necrosis. This process also activates anti-tumour immunity, enhancing the eradication of cancer cells.      

Latest Issue
Get instant
access to our latest e-book
THERMOFISHER SEACertara - Is your drug program on trackMasterControl - Manufacturing demoMasterControl - QMS demoThermo Fisher Scientific - Rapid Mycoplasma TestingThermoFisher Scientific - Save costs on your downstream process todayThermo Fisher Scientific - PeptonesMerck - Mobius® products5th Annual Pharma Manufacturing and Automation Convention 2023DUPHAT 202410TH ANNUAL GCC PHARMACY CONGRESS 202314th Annual Emirates Cardiac Society Conference 2023The International Hand & Wrist Congress 2023LabAsia 2023Pharma & Patient USA 2023Pharma Customer Engagement Europe 2023CHEMICAL INDONESIA 2024INALAB 2024